LivaNova PLC Company Profile (NASDAQ:LIVN)

About LivaNova PLC (NASDAQ:LIVN)

LivaNova PLC logoLivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company's segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Cardiac Rhythm Management segment is engaged in the development, manufacturing and marketing of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Cardiac Rhythm Management products include high-voltage defibrillators Cardiac Resynchronization Therapy device (CRT-D) and low-voltage pacemakers. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:LIVN
  • CUSIP: N/A
  • Web: www.livanova.com
Capitalization:
  • Market Cap: $2.83 billion
  • Outstanding Shares: 48,838,000
Average Prices:
  • 50 Day Moving Avg: $54.82
  • 200 Day Moving Avg: $49.15
  • 52 Week Range: $40.83 - $63.21
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 16.91
  • P/E Growth: 1.34
Sales & Book Value:
  • Annual Revenue: $1.21 billion
  • Price / Sales: 2.34
  • Book Value: $36.05 per share
  • Price / Book: 1.61
Profitability:
  • EBIDTA: $193.82 million
  • Net Margins: -5.51%
  • Return on Equity: 4.42%
  • Return on Assets: 3.15%
Debt:
  • Debt-to-Equity Ratio: 0.05%
  • Current Ratio: 2.04%
  • Quick Ratio: 1.42%
Misc:
  • Average Volume: 323,703 shs.
  • Beta: 0.7
  • Short Ratio: 7.11
 

Frequently Asked Questions for LivaNova PLC (NASDAQ:LIVN)

What is LivaNova PLC's stock symbol?

LivaNova PLC trades on the NASDAQ under the ticker symbol "LIVN."

How were LivaNova PLC's earnings last quarter?

LivaNova PLC (NASDAQ:LIVN) issued its quarterly earnings data on Wednesday, May, 3rd. The company reported $0.71 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.68 by $0.03. The company had revenue of $285.10 million for the quarter. LivaNova PLC had a negative net margin of 5.51% and a positive return on equity of 4.42%. View LivaNova PLC's Earnings History.

What guidance has LivaNova PLC issued on next quarter's earnings?

LivaNova PLC updated its FY17 earnings guidance on Friday, March, 31st. The company provided earnings per share (EPS) guidance of $3.25-3.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.15.

Where is LivaNova PLC's stock going? Where will LivaNova PLC's stock price be in 2017?

4 equities research analysts have issued twelve-month price objectives for LivaNova PLC's shares. Their predictions range from $54.00 to $70.00. On average, they anticipate LivaNova PLC's share price to reach $61.33 in the next twelve months. View Analyst Ratings for LivaNova PLC.

Who are some of LivaNova PLC's key competitors?

Who owns LivaNova PLC stock?

LivaNova PLC's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (9.86%), BlackRock Inc. (5.31%), Columbia Wanger Asset Management LLC (4.22%), FIL Ltd (4.02%), Renaissance Technologies LLC (2.88%) and Camber Capital Management LLC (2.46%). Company insiders that own LivaNova PLC stock include Alfred J Novak, Daniel Jeffrey Moore, Hugh M Morrison, Jacques Gutedel, Sharon O'kane and Two SCA Equinox. View Institutional Ownership Trends for LivaNova PLC.

Who sold LivaNova PLC stock? Who is selling LivaNova PLC stock?

LivaNova PLC's stock was sold by a variety of institutional investors in the last quarter, including FIL Ltd, Credit Agricole S A, Renaissance Technologies LLC, Legal & General Group Plc, JPMorgan Chase & Co., Eagle Asset Management Inc., Wells Fargo & Company MN and Nationwide Fund Advisors. Company insiders that have sold LivaNova PLC stock in the last year include Alfred J Novak, Daniel Jeffrey Moore, Hugh M Morrison, Jacques Gutedel and Two SCA Equinox. View Insider Buying and Selling for LivaNova PLC.

Who bought LivaNova PLC stock? Who is buying LivaNova PLC stock?

LivaNova PLC's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, Credit Suisse AG, Point72 Asset Management L.P., Epoch Investment Partners Inc., Dimensional Fund Advisors LP, Investment Counselors of Maryland LLC and Spark Investment Management LLC. View Insider Buying and Selling for LivaNova PLC.

How do I buy LivaNova PLC stock?

Shares of LivaNova PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of LivaNova PLC stock cost?

One share of LivaNova PLC stock can currently be purchased for approximately $58.00.

Analyst Ratings

Consensus Ratings for LivaNova PLC (NASDAQ:LIVN) (?)
Ratings Breakdown: 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $61.33 (5.75% upside)

Analysts' Ratings History for LivaNova PLC (NASDAQ:LIVN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/10/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
2/6/2017Canaccord GenuityReiterated RatingHold$54.00N/AView Rating Details
8/31/2016WBB SecuritiesReiterated RatingHold$60.00N/AView Rating Details
8/5/2016Piper Jaffray CompaniesReiterated RatingOverweight$59.00 -> $70.00N/AView Rating Details
2/29/2016Kepler Capital MarketsBoost Price TargetHold$63.00 -> $66.00N/AView Rating Details
10/21/2015Berenberg BankInitiated CoverageBuy$80.00N/AView Rating Details
(Data available from 5/28/2015 forward)

Earnings

Earnings History for LivaNova PLC (NASDAQ:LIVN)
Earnings by Quarter for LivaNova PLC (NASDAQ:LIVN)
Earnings History by Quarter for LivaNova PLC (NASDAQ:LIVN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/20173/31/2017$0.68$0.71$285.10 millionViewListenView Earnings Details
3/1/2017Q416$0.79$0.82$301.45 million$310.60 millionViewListenView Earnings Details
11/2/2016Q316$0.76$0.78$299.40 million$295.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for LivaNova PLC (NASDAQ:LIVN)
Current Year EPS Consensus Estimate: $3.07 EPS
Next Year EPS Consensus Estimate: $3.43 EPS

Dividends

Dividend History for LivaNova PLC (NASDAQ:LIVN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for LivaNova PLC (NASDAQ:LIVN)
Insider Ownership Percentage: 0.70%
Institutional Ownership Percentage: 66.11%
Insider Trades by Quarter for LivaNova PLC (NASDAQ:LIVN)
Institutional Ownership by Quarter for LivaNova PLC (NASDAQ:LIVN)
Insider Trades by Quarter for LivaNova PLC (NASDAQ:LIVN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/23/2017Sharon O'kaneDirectorBuy1,000$58.58$58,580.00View SEC Filing  
5/22/2017Alfred J NovakDirectorSell1,000$58.49$58,490.00View SEC Filing  
5/5/2017Hugh M MorrisonDirectorSell3,215$55.89$179,686.35View SEC Filing  
4/17/2017Daniel Jeffrey MooreDirectorSell1,000$51.32$51,320.00View SEC Filing  
3/15/2017Daniel Jeffrey MooreDirectorSell1,000$50.21$50,210.00View SEC Filing  
9/22/2016Two S.C.A. EquinoxMajor ShareholderSell185,000$61.54$11,384,900.00View SEC Filing  
9/21/2016Two S.C.A. EquinoxMajor ShareholderSell391,379$60.69$23,752,791.51View SEC Filing  
9/16/2016Two S.C.A. EquinoxMajor ShareholderSell75,213$59.86$4,502,250.18View SEC Filing  
9/13/2016Two S.C.A. EquinoxMajor ShareholderSell25,408$60.02$1,524,988.16View SEC Filing  
9/8/2016Two S.C.A. EquinoxMajor ShareholderSell208,000$60.52$12,588,160.00View SEC Filing  
8/9/2016Jacques GutedelInsiderSell4,000$60.52$242,080.00View SEC Filing  
5/24/2016Daniel Jeffrey MooreDirectorSell1,000$50.07$50,070.00View SEC Filing  
5/19/2016Hugh M MorrisonDirectorSell3,600$48.00$172,800.00View SEC Filing  
5/6/2016Alfred J NovakDirectorSell4,000$51.12$204,480.00View SEC Filing  
4/15/2016Daniel Jeffrey MooreDirectorSell1,000$54.81$54,810.00View SEC Filing  
3/15/2016Daniel Jeffrey MooreDirectorSell1,000$56.88$56,880.00View SEC Filing  
2/16/2016Daniel Jeffrey MooreDirectorSell1,000$56.88$56,880.00View SEC Filing  
1/15/2016Daniel Jeffrey MooreDirectorSell1,000$52.64$52,640.00View SEC Filing  
12/15/2015Daniel Jeffrey MooreDirectorSell2,500$53.97$134,925.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for LivaNova PLC (NASDAQ:LIVN)
Latest Headlines for LivaNova PLC (NASDAQ:LIVN)
Source:
DateHeadline
americanbankingnews.com logoLivaNova PLC (LIVN) Director Sharon O'kane Purchases 1,000 Shares
www.americanbankingnews.com - May 24 at 8:24 PM
americanbankingnews.com logoAlfred J. Novak Sells 1,000 Shares of LivaNova PLC (LIVN) Stock
www.americanbankingnews.com - May 23 at 8:18 PM
seekingalpha.com logoLivaNova (LIVN) Presents At Bank of America Merrill Lynch 2017 Health Care Conference - Slideshow
seekingalpha.com - May 19 at 6:00 PM
americanbankingnews.com logoLivaNova PLC (LIVN) Director Hugh M. Morrison Sells 3,215 Shares
www.americanbankingnews.com - May 9 at 4:37 PM
finance.yahoo.com logoLivaNova PLC to Present at the Bank of America Merrill Lynch and Jefferies Conferences
finance.yahoo.com - May 9 at 12:00 PM
americanbankingnews.com logoLivaNova PLC (LIVN) Releases Earnings Results, Beats Estimates By $0.03 EPS
www.americanbankingnews.com - May 5 at 11:53 PM
finance.yahoo.com logoLivaNova Announces New Data Reaffirming Value of Perceval for Aortic Valve Replacement in Aortic Stenosis Patients
finance.yahoo.com - May 4 at 11:56 AM
americanbankingnews.com logoLivaNova PLC (LIVN) Getting Somewhat Negative Press Coverage, AlphaOne Reports
www.americanbankingnews.com - May 4 at 11:17 AM
finance.yahoo.com logoLivaNova Reports First Quarter 2017 Results
finance.yahoo.com - May 3 at 8:45 AM
finance.yahoo.com logoLivaNova posts 1Q profit
finance.yahoo.com - May 3 at 8:45 AM
finance.yahoo.com logoInvestor Network: Livanova PLC to Host Earnings Call
finance.yahoo.com - May 3 at 8:45 AM
americanbankingnews.com logoLivaNova PLC (LIVN) Given News Impact Rating of -0.23
www.americanbankingnews.com - April 30 at 7:52 AM
finance.yahoo.com logoLivaNova to Unveil New Data Further Demonstrating the Perceval Sutureless Valve is a Safe and Effective Aortic Valve Replacement for Patients
finance.yahoo.com - April 28 at 7:14 PM
americanbankingnews.com logoLivaNova PLC (LIVN) Earning Very Favorable News Coverage, Analysis Finds
www.americanbankingnews.com - April 27 at 10:04 AM
americanbankingnews.com logoLivaNova PLC (LIVN) Getting Somewhat Positive Press Coverage, Report Finds
www.americanbankingnews.com - April 24 at 8:42 PM
americanbankingnews.com logoLivaNova PLC (LIVN) Receiving Positive Press Coverage, Report Finds
www.americanbankingnews.com - April 21 at 10:27 PM
americanbankingnews.com logoLivaNova PLC (LIVN) Director Sells $51,320.00 in Stock
www.americanbankingnews.com - April 19 at 8:23 PM
americanbankingnews.com logoLivaNova PLC (LIVN) Receiving Very Favorable Media Coverage, Study Finds
www.americanbankingnews.com - April 17 at 9:14 AM
americanbankingnews.com logoLivaNova PLC (LIVN) Receiving Somewhat Favorable Media Coverage, Study Finds
www.americanbankingnews.com - April 14 at 2:46 PM
americanbankingnews.com logoShort Interest in LivaNova PLC (LIVN) Decreases By 1.6%
www.americanbankingnews.com - April 10 at 3:46 PM
finance.yahoo.com logoLivaNova Recognizes World Health Day Focus on Depression
finance.yahoo.com - April 7 at 10:49 AM
americanbankingnews.com logoLivaNova PLC (LIVN) Receives Hold Rating from Canaccord Genuity
www.americanbankingnews.com - April 2 at 11:06 AM
streetinsider.com logoLivaNova plc (LIVN) CFO to Depart
www.streetinsider.com - April 2 at 10:14 AM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces an Investigation of LivaNova PLC and Advises Investors with Losses to Contact the Firm
finance.yahoo.com - April 1 at 12:09 PM
uk.finance.yahoo.com logoLivaNova PLC Reiterates Full-Year 2017 Guidance
uk.finance.yahoo.com - March 31 at 6:19 PM
finance.yahoo.com logoGlancy Prongay & Murray LLP Commences Investigation on Behalf of LivaNova PLC Investors
finance.yahoo.com - March 31 at 6:19 PM
uk.finance.yahoo.com logoLivaNova PLC Announces Chief Financial Officer Resignation
uk.finance.yahoo.com - March 31 at 9:53 AM
biz.yahoo.com logoLIVANOVA PLC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial State
biz.yahoo.com - March 31 at 9:53 AM
uk.finance.yahoo.com logoLivaNova to Host Conference Call for First Quarter 2017 Results
uk.finance.yahoo.com - March 29 at 6:52 PM
nasdaq.com logoCamber Capital Management LLC Buys Allergan PLC, Myriad Genetics, Vertex Pharmaceuticals, Sells ...
www.nasdaq.com - March 17 at 9:12 AM
finance.yahoo.com logoLIVANOVA PLC Financials
finance.yahoo.com - March 7 at 6:03 PM
biz.yahoo.com logoLIVANOVA PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - March 1 at 11:13 AM
businesswire.com logoLivaNova PLC - LIVN Intended Delisting and Cancellation of Ordinary Shares from London Stock Exchange
www.businesswire.com - February 23 at 6:17 PM
uk.finance.yahoo.com logoLivaNova PLC Announces Its Intent to Delist from London Stock Exchange
uk.finance.yahoo.com - February 23 at 6:17 PM
uk.finance.yahoo.com logoLivaNova Recognizes International Epilepsy Day
uk.finance.yahoo.com - February 13 at 10:39 AM
us.rd.yahoo.com logo1:05 pm LivaNova announces a data presentation on the Perceval sutureless valve was unveiled at The Society of Thoracic Surgeons 53rd Annual Meeting; study found that AVR procedures conducted with Perceval resulted in low mortality & 'excel
us.rd.yahoo.com - January 28 at 3:58 AM
businesswire.com logoNew Data Reinforce the Clinical Value of the Perceval Sutureless Valve as a Safe and Effective Bioprosthesis for Patients in Need of Aortic Valve Replacement
www.businesswire.com - January 27 at 10:57 PM
businesswire.com logoLivaNova PLC: Notice of Results
www.businesswire.com - January 25 at 7:42 PM
uk.finance.yahoo.com logoLivaNova to Host Conference Call for Fourth Quarter 2016 Results
uk.finance.yahoo.com - January 25 at 7:42 PM
uk.finance.yahoo.com logoLivaNova PLC to Present at the Berenberg European Conference
uk.finance.yahoo.com - December 1 at 6:17 PM
uk.finance.yahoo.com logoLivaNova PLC to Present at the Jefferies and Piper Jaffray Conferences
uk.finance.yahoo.com - November 11 at 5:36 PM
globenewswire.com logoLivaNova Reports Third Quarter 2016 Results
globenewswire.com - November 2 at 9:29 AM
seekingalpha.com logoLivaNova PLC beats by $0.03, misses on revenue
seekingalpha.com - November 2 at 9:29 AM
streetinsider.com logoLivaNova plc (LIVN) Tops Q3 EPS by 3c; Appoints New CEO
www.streetinsider.com - November 2 at 9:29 AM
finance.yahoo.com logoLivaNova PLC to Present at the Credit Suisse Annual Healthcare Conference
finance.yahoo.com - October 24 at 11:15 AM
wsj.com logo[$$] CDC Links Bacterial Infection in Patients to LivaNova Surgical Device
www.wsj.com - October 14 at 9:13 AM
uk.finance.yahoo.com logoU.S. health officials warn of infection risk from heart surgery device
uk.finance.yahoo.com - October 13 at 5:59 PM
finance.yahoo.com logoLivaNova PLC Announces Participation in 30th EACTS Annual Meeting
finance.yahoo.com - September 30 at 11:07 AM
seekingalpha.com logoThird Avenue Value Fund 3Q16 Commentary
seekingalpha.com - September 22 at 5:41 PM
finance.yahoo.com logoLivaNova Launches Next Generation ICD and CRT-D Devices in the United States
finance.yahoo.com - September 22 at 5:41 PM

Social

Chart

LivaNova PLC (LIVN) Chart for Sunday, May, 28, 2017

This page was last updated on 5/28/2017 by MarketBeat.com Staff